insights_auto
Why is SABS down 5.68%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
$2.90
arrow_downward
-5.68%(-0.17) 1D
Nov 13, 10:33:27 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
$3.08
High
$3.15
Low
$2.90
Mkt. cap
261.71M
Avg. vol.
700.24K
Volume
138.47K
52-wk high
$5.15
52-wk low
$2.44
EPS
-$0.93
Beta
0.67
Shares outstanding
90.09M
No. of employees
86
Open
$3.08
High
$3.15
Low
$2.90
Mkt. cap
261.71M
Avg. vol.
700.24K
Volume
138.47K
52-wk high
$5.15
52-wk low
$2.44
EPS
-$0.93
Beta
0.67
Shares outstanding
90.09M
No. of employees
86
News stories
From web sources and news partners
Reuters
·
1 hour ago
Goldman Sachs sees S&P 500 rising to 8,700 next year despite slower earnings growth
Investopedia
·
40 minutes ago
Stock Market Today: S&P 500, Nasdaq Slip in Early Trading as Nvidia Shares Continue Falling; Major Indexes Remain on Track for Big Weekly Gains
Yahoo Finance
·
1 hour ago
Wall Street Divided on S&P 500: Which ETFs Could Benefit in 2027?
ChartMill
·
1 hour ago
S&P 500 Premarket Movers: Travelers, Palo Alto Networks Gain; Cisco, AMD Fall
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
HeadquartersMiami Beach, Florida, United States
SectorHealth Care
IndustryBiotechnology
Websitesab.bio